Covid-19 Diagnostics Market by Product (PCR Kits, POC Kits and Immunoassay), Technology (Molecular and Immunoassay), and End User (Hospitals, Physician's office & urgent care clinics and Diagnostic Labs): Global Opportunity Analysis and Industry Forecast, 20202022
- Published Date: 2020-11-18
- Report ID: 18200
- Pages: 275
-
Format:
The global covid-19 diagnostics market size is anticipated to reach $780 million till the end of 2020. Covid-19 is an infectious disease caused by a newly discovered coronavirus with a nomenclature Sars Cov 2.The virus strain shows significant similarity with an earlier detected virus, Sars Cov. The virus outbreak started from Wuhan city of China and is now spread across 210 countries and territories around the world and 2 international conveyances, as per Worldometer data.
Significant increase in the incidences of covid-19 across the globe and rise in mortality rates due to the outbreak are the major factors that drive the market growth. Moreover, technological developments and introduction of various test kits by companies worldwide propels the market growth. However, dearth of diagnosis kits in developing economies is anticipated to hamper the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a fast pace.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current Covid-19 diagnostics market trends and forecast estimations from 2020 to 2022, which assists to identify the prevailing market opportunities.
An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
A comprehensive analysis of factors that drive and restrain the covid-19 market growth is provided.
The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2022, in terms of value.
An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
Key players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook.
KEY MARKET SEGMENTS
By Product
o PCR Kits
o POC Kits
o Immuno Assay
By Technology
Molecular
Immunoassay
By End User
Hospitals
Physician's office and urgent care clinics
Diagnostic Labs
By Region
o North America
U.S.
Canada
Mexico
Rest of North America
o Europe
UK
Germany
France
Spain
Italy
Estonia
Austria
Czech Republic
Rest of Europe
o Asia-Pacific
China
India
Australia
Japan
South Korea
Thailand
Malaysia
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Israel
Rest of LAMEA
KEY MARKET PLAYERS
F. Hoffmann-La Roche AG
Seegene Inc.
Cepheid
Mylab Lifesolutions Pvt. Ltd.
SureScreen Diagnostics Ltd
Thermo Fisher Scientific
Genematrix
Robert Bosch GmbH
Cellex
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Porter's five forces analysis
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Significant increase in the incidence of covid-19 infection
3.3.1.2.Unavailability of specific medicine/ vaccine
3.3.2.Restraints
3.3.2.1.Lack of covid-19 diagnosis kits
3.3.3.Opportunities
3.3.3.1.Various growth opportunities in emerging economies
CHAPTER 4:GLOBAL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY
4.1.Overview
4.1.1.Approved covid-19 Diagnostic Products
4.1.2.Market size and forecast, By Technology
4.2.Molecular Assay
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.3.Immunoassay/Serology
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
CHAPTER 5:COVID-19 DIAGNOSTICS MARKET, BY PRODUCT
5.1.Overview
5.1.1.Market size and forecast, by product
5.2.PCR Kits
5.2.1.Market size and forecast, by region
5.3.Immunoassay Cassettes/Strips
5.3.1.Market size and forecast, by region
5.4.POC (Point of care) test
5.4.1.Market size and forecast, by region
CHAPTER 6:GLOBAL COVID-19 DIAGNOSTICS MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast, by end user
6.2.Hospitals
6.2.1.Market size and forecast, by region
6.3.Diagnostics Laboratory
6.3.1.Market size and forecast, by region
6.4.Physician's office and urgent care clinics
6.4.1.Market size and forecast, by region
CHAPTER 7:COVID-19 DIAGNOSTICS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S. market size and forecast, By Technology
7.2.2.2.U.S. market size and forecast, by product
7.2.2.3.U.S. market size and forecast, by end user
7.2.2.4.Canada market size and forecast, By Technology
7.2.2.5.Canada market size and forecast, by product
7.2.2.6.Canada. market size and forecast, by end user
7.2.2.7.Mexico market size and forecast, By Technology
7.2.2.8.Mexico market size and forecast, by product
7.2.2.9.Mexico. market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends
7.3.2.Market size and forecast, by country
7.3.2.1.France market size and forecast, By Technology
7.3.2.2.France market size and forecast, by product
7.3.2.3.France. market size and forecast, by end user
7.3.2.4.UK market size and forecast, By Technology
7.3.2.5.UK market size and forecast, by product
7.3.2.6.UK. market size and forecast, by end user
7.3.2.7.Germany market size and forecast, By Technology
7.3.2.8.Germany market size and forecast, by product
7.3.2.9.Germany market size and forecast, by end user
7.3.2.10.Spain market size and forecast, By Technology
7.3.2.11.Spain market size and forecast, by product
7.3.2.12.Spain market size and forecast, by end user
7.3.2.13.Italy market size and forecast, By Technology
7.3.2.14.Italy market size and forecast, by product
7.3.2.15.Italy market size and forecast, by end user
7.3.2.16.Austria market size and forecast, by technology
7.3.2.17.Austria market size and forecast, by product
7.3.2.18.Austria market size and forecast, by end user
7.3.2.19.Estonia market size and forecast, by technology
7.3.2.20.Estonia market size and forecast, by product
7.3.2.21.Estonia market size and forecast, by end user
7.3.2.22.Czech Republic market size and forecast, by technology
7.3.2.23.Czech Republic market size and forecast, by product
7.3.2.24.Czech Republic market size and forecast, by end user
7.3.2.25.Rest of Europe market size and forecast, By Technology
7.3.2.26.Rest of Europe market size and forecast, by product
7.3.2.27.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan market size and forecast, by technology
7.4.2.2.Japan market size and forecast, by product
7.4.2.3.Japan market size and forecast, by end user
7.4.2.4.China market size and forecast, by technology
7.4.2.5.China market size and forecast, by product
7.4.2.6.China market size and forecast, by end user
7.4.2.7.India market size and forecast, by technology
7.4.2.8.India market size and forecast, by product
7.4.2.9.India market size and forecast, by end user
7.4.2.10.Australia market size and forecast, by technology
7.4.2.11.Australia market size and forecast, by product
7.4.2.12.Australia market size and forecast, by end user
7.4.2.13.South Korea market size and forecast, by technology
7.4.2.14.South Korea market size and forecast, by product
7.4.2.15.South Korea market size and forecast, by end user
7.4.2.16.Thailand market size and forecast, by technology
7.4.2.17.Thailand market size and forecast, by product
7.4.2.18.Thailand market size and forecast, by end user
7.4.2.19.Malaysia market size and forecast, by technology
7.4.2.20.Malaysia market size and forecast, by product
7.4.2.21.Malaysia market size and forecast, by end user
7.4.2.22.Rest of Asia-Pacific market size and forecast, by technology
7.4.2.23.Rest of Asia-Pacific market size and forecast, by product
7.4.2.24.Rest of Asia-Pacific market size and forecast, by end user
7.4.3.LAMEA
7.4.4.Key market trends and opportunities
7.4.5.Market size and forecast, by country
7.4.5.1.Brazil market size and forecast, by technology
7.4.5.2.Brazil market size and forecast, by product
7.4.5.3.Brazil market size and forecast, by end user
7.4.5.4.South Africa market size and forecast, by technology
7.4.5.5.South Africa market size and forecast, by product
7.4.5.6.South Africa market size and forecast, by end user
7.4.5.7.Saudi Arabia market size and forecast, by technology
7.4.5.8.Saudi Arabia market size and forecast, by product
7.4.5.9.Saudi Arabia market size and forecast, by end user
7.4.5.10.Israel market size and forecast, by technology
7.4.5.11.Israel market size and forecast, by product
7.4.5.12.Israel market size and forecast, by end user
7.4.5.13.Rest of LAMEA market size and forecast, by technology
7.4.5.14.Rest of LAMEA market size and forecast, by product
7.4.5.15.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.Abbott Laboratories
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.Cellex Incorporated
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.3.Cepheid
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.F. Hoffmann-La Roche Ltd.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance.
8.4.6.Key strategic moves and developments
8.5.Hologic, Inc.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.Laboratory Corp of America Holdings
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.Mylab Discovery Solutions Pvt. Ltd.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Key strategic moves and developments
8.8.Quest Diagnostics Incorporated
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.Seegene Inc.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments
8.10.Thermo Fisher Scientific, Inc.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
